Individuals inheriting mutations in the DNA-binding domain of the TP53 gene (e.g., R175H or R248W) are at high risk of developing various tumors, such as breast, brain, soft tissue, and bone cancers, often at a young age [37]. This evidence concerns the gene TP53 and bone neoplasm.